AzTrials
AzTrials

Arthroplasty, Replacement, HipLFITNCT00510458

LFIT™ Anatomic CoCr Femoral Heads With X3® Polyethylene Insert Study

A study testing LFIT™ Femoral Heads With X3® Insert in people with Arthroplasty, Replacement, Hip, run by Stryker Orthopaedics at 5 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Total hip replacement surgery is considered to be a very successful surgical procedure for the treatment of degenerative joint disease. The purpose of the study is to evaluate a large size (36mm, 40mm or 44mm) femoral (hip) head called the LFIT™ Anatomic CoCr Femoral Head (Low Friction Ion Treatment). Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Arthroplasty, Replacement, Hip
What is being tested?
LFIT™ Femoral Heads With X3® Insert
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
89 participants
Where
5 sitesUnited States
Study dates
Apr 2007to Dec 2016
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patient is candidate for a primary cementless total hip replacement, and a posterolateral surgical approach is planned.
  • Patient's preoperative templating predicts the use of a Hemispherical Acetabular Shell size 52mm or larger.
  • Patient has primary diagnosis of Non-Inflammatory Degenerative Joint Disease (NIDJD). Patient must have diagnosis of osteoarthritis (OA), traumatic arthritis (TA), avascular necrosis (AVN), slipped capital epiphysis, pelvic fracture, femoral fracture, failed fracture fixation, or diastrophic variant
  • Patient is a male or non-pregnant female age 18 years or older at time of enrollment.
  • Patient has signed an IRB approved, study specific Informed Patient Consent Form.
  • Patient is willing and able to comply with postoperative scheduled clinical and radiographic evaluations and rehabilitation.

Who cannot join

  • Patient has an active infection within the affected hip joint.
  • Patient requires revision surgery of a previously implanted total hip arthroplasty or hip fusion to the affected joint.
  • Patient has a Body Mass Index (BMI) ≥ 40.
  • Patient has a neuromuscular or neurosensory deficiency, which limits ability to evaluate the safety and efficacy of the device.
  • Patient is diagnosed with systemic disease or current life threatening illness and is not able to carry on normal activities of daily life (i.e. Paget's disease, renal osteodystrophy, rheumatoid arthritis).
  • Patient is immunologically suppressed or receiving chronic steroids in excess of 5mg per day.
  • Patient has a recent history of substance dependency that may result in deviations from the evaluation schedule.
  • Patient is a prisoner.

Trial locations and contacts

5 sites in 1 country.

5 sites in 1 country

United States5 sites
  • The Center: Orthopedic & Neurosurgical Care & Research

    Bend, Oregon, 97701

  • Tufts Medical Center

    Boston, Massachusetts, 02111

  • Cedars Medical Center University of Miami

    Miami, Florida, 33136

  • Greater Pittsburgh Orthopaedic Associates

    Moon Township, Pennsylvania, 15108

  • Seaview Orthopedics

    Ocean City, New Jersey, 07712

Other trials in United States

About this study

Official title: LFIT™ Anatomic CoCr Femoral Heads With X3® Polyethylene Insert Study - An Open Label, Prospective, Post-market, Multi-center Clinical Evaluation of the LFIT™ Anatomic CoCr Femoral Heads With X3® Inserts

Total hip replacement surgery is considered to be a very successful surgical procedure for the treatment of degenerative joint disease. The purpose of the study is to evaluate a large size (36mm, 40mm or 44mm) femoral (hip) head called the LFIT™ Anatomic CoCr Femoral Head (Low Friction Ion Treatment). The large size femoral heads will be used with the Trident® X3® polyethylene (plastic) inserts and will be compared with a historical control. Study Hypothesis: The linear wear rate for hips implanted with the LFIT™ Anatomic CoCr Femoral Head is no worse than 0.08 mm wear per year at 5 years post-surgery.

Being tested
LFIT™ Femoral Heads With X3® Insert

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • LFIT™ Femoral Heads With X3® InsertDevice

    LFIT™ Anatomic CoCr Femoral Heads With X3® Polyethylene Insert in total hip replacement

Study groups in NCT00510458
Study groupRoleWhat they receive
LFIT™Femoral Heads With X3® InsertOtherLFIT™ Femoral Heads With X3® Insert
Receives: Device: LFIT™ Femoral Heads With X3® Insert

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Linear Wear Rate

    Linear wear rate is defined as the annual rate of removal of the polyethylene from the X3 polyethylene insert mated with LFIT™ Anatomic CoCr Femoral Heads determined by comparing digitized images of serial radiographs obtained over the follow-up period.

    .

    Measured: 5 Years Post-Surgery

Secondary outcomes (8)
  1. Change in Harris Hip Score (HHS) From Pre-operative to Post-operative Visits

    The change in HHS is reported by comparing the mean preoperative, 1, 3, and 5 year scores. The HHS assesses pain, function, joint deformity and range of motion. Scores can range from 0 to 100 with 0 being the worst and 100 being the best score. A score of 80-100 is considered good-excellent and a score of less than or equal to 79 is considered fair-poor.

    90-100 = excellent 80-89 = good 70-79 = fair 0-69 = poor

    Measured: preoperative, 1, 3, and 5 years

  2. Change in Harris Hip Score (HHS) Pain Score From Pre-operative to Post-operative Visits

    This subscore of the overall HHS provides the patient with 6 possible answers to choose from ranging from, no pain/ignores it, to totally disabled/crippled/pain in bed/bedridden. A maximum of 44 points is possible for this subscore indicating no pain/ignores it.

    Pain:

    1. None or ignores it = 44 points
    2. Slight, occasional, no compromise in activities = 40 points
    3. Mild pain, no effect on average activities, rarely moderate pain with unusual activity, may take aspirin = 30 points
    4. Moderate pain, tolerable but makes concessions to pain. Some limitation of ordinary activity or work. May require occasional pain medicine stronger than aspirin = 20 points
    5. Marked pain, serious limitation of activities = 10 points
    6. Totally disabled, crippled, pain in bed, bedridden = 0 points

    Measured: preop, 1, 3, and 5 Years

  3. Change in Harris Hip Score (HHS) Range of Motion (ROM) Score From Pre-operative to Post-operative Visits.

    This subscore of the overall HHS includes the total points awarded for five different ranges of motion (flexion, abduction, external rotation, internal rotation, adduction). Subscore range is minimum of 0 to maximum of 5 points; the higher the value, the better the outcome.

    Flexion:

    0-45 degrees x 1.0 index value = max 45 points

    45-90 degrees x 0.6 index = max 27 points

    90-110 degrees x 0.3 index = max 6 points

    110-130 degrees = max 0 points

    Abduction:

    0-15 degrees x 0.8 index = max 12 points

    15-20 degrees x 0.3 index = max 1.5 points

    20-45 degrees x 0 index = max 0 points

    External Rotation in extension:

    0-15 degrees x 0.4 index = max 6 points

    Over 15 degrees = max 0 points

    Internal Rotation in extension:

    Any = max 0 points

    Adduction:

    0-15 degrees x 0.2 index = max 3 points

    Over 15 degrees - max 0 points

    To determine the over-all rating for range of motion, multiply the sum of the index values x 0.05.

    Measured: preoperative, 1, 3, and 5 Years

  4. Change in SF-12 Health Survey Score (Physical and Mental) From Pre-operative to Post-operative Intervals.

    The change in SF-12 is reported by comparing the mean preoperative, 1, 3, and 5 year scores. The SF-12 Health Survey is a 12 item patient completed questionnaire to measure general health and well-being. It includes a physical component score and mental status component score; each ranging from 0-100. Low values represent a poor health state and high values represent a good health state.

    Measured: preop, 1, 3, and 5 Years

  5. Change in Lower Extremity Activity Scale (LEAS) From Pre-operative to Post-operative

    The change in LEAS is reported by comparing the mean pre-operative, 1,3,and 5 year scores. The LEAS completed by the participant to assess activity level. Activity levels were ordered in terms of intensity from 1 to 18, with 18 indicating the highest activity level.

    Measured: preoperative, 1, 3, and 5 Years

  6. Number of Hips That Dislocated

    The number of hips that experienced a hip dislocation.

    Measured: 3 and 5 years

  7. Number of Hips Evaluated as Radiographically Unstable

    Radiographic instability is defined as having any of the following findings on x-ray:

    • Radiographic indication of progressive radiolucent lines ≥ 2 mm in thickness around the entire acetabular component
    • Radiographic indication of migration of ≥ 3 mm or ≥ 5° of the acetabular component
    • Radiographic indication of progressive radiolucent lines ≥ 2 mm thickness around the entire femoral component
    • Radiographic indication of progressive subsidence of the femoral component of ≥ 5 mm.

    Measured: 1, 3, 5 years

  8. Percentage of Cases That Did Not Have Any Component Revised

    A revision is defined as surgical removal and replacement of the femoral bearing head or femoral stem components, or the acetabular shell or acetabular polyethylene liner.

    The 97.42% estimate is obtained by Kaplan-Meier method.

    Measured: 5 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Aug 2007 (estimated)
  2. Study startApr 2007
  3. Primary completionDec 2016
  4. Study completionDec 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
89 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00510458
Sponsor's protocol ID
63
Acronym
LFIT
Status last verified
Jan 2018
First submitted
1 Aug 2007
Last updated
12 Mar 2018
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing LFIT™ Femoral Heads With X3® Insert in people with Arthroplasty, Replacement, Hip, run by Stryker Orthopaedics at 5 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 Mar 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 5 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 12 Mar 2018). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Linear Wear Rate (time frame: 5 Years Post-Surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Mar 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in